Department of Endocrine Surgery, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Thyroid. 2024 Jan;34(1):64-69. doi: 10.1089/thy.2023.0360. Epub 2023 Dec 11.
The impact of near-infrared autofluorescence (NIRAF) imaging on postthyroidectomy hypocalcemia is controversial. As patients with Graves' disease are at increased risk, our aim was to compare postoperative parathyroid function in these patients undergoing total thyroidectomy (TT) with or without NIRAF imaging. This was a retrospective "before and after" study, comparing outcomes of patients who underwent TT without or with NIRAF imaging at a single center. Primary outcome was the incidence of temporary hypocalcemia and secondary outcomes, rates of incidental parathyroidectomy on final specimens and permanent hypocalcemia. Analyses were performed using Mann-Whitney U and chi-Square tests. Continuous data are expressed as median (interquartile range). There were 85 patients in NIRAF and 100 patients in non-NIRAF group. Groups were comparable regarding age, gender, body-mass index, and thyroid weight. Number of parathyroid glands identified intraoperatively was 3 in both groups ( = 0.47). Intraoperative parathyroid implantation rate was 16.5% in NIRAF and 6% in non-NIRAF group ( = 0.02). Incidental parathyroidectomy rate on final pathology was 12.9% in NIRAF and 32% in non-NIRAF group ( = 0.002). The rates of temporary (11.7% vs. 16%) and permanent hypocalcemia (2.4% vs. 2%) were similar between the two groups, respectively ( = 0.66). To our knowledge, this is the first comparative study investigating the impact of NIRAF on postoperative parathyroid function after thyroidectomy for Graves' disease. The rate of incidental parathyroidectomy on final pathology was lower with use of NIRAF, without an impact on temporary or permanent hypocalcemia rates compared to conventional technique.
近红外自发荧光(NIRAF)成像对甲状腺切除术后低钙血症的影响存在争议。由于格雷夫斯病患者的风险增加,我们的目的是比较这些接受甲状腺全切除术(TT)的患者在有无 NIRAF 成像的情况下术后甲状旁腺功能。这是一项回顾性的“前后”研究,比较了在一家中心接受 TT 且有无 NIRAF 成像的患者的结果。主要结局是暂时性低钙血症的发生率,次要结局是最终标本上偶然甲状旁腺切除术的发生率和永久性低钙血症。使用 Mann-Whitney U 和卡方检验进行分析。连续数据表示为中位数(四分位距)。NIRAF 组有 85 例,非 NIRAF 组有 100 例。两组在年龄、性别、体重指数和甲状腺重量方面具有可比性。两组术中识别的甲状旁腺数量均为 3 个(=0.47)。NIRAF 组术中甲状旁腺植入率为 16.5%,非 NIRAF 组为 6%(=0.02)。最终病理上偶然甲状旁腺切除术的发生率在 NIRAF 组为 12.9%,在非 NIRAF 组为 32%(=0.002)。两组暂时性(11.7% vs. 16%)和永久性低钙血症(2.4% vs. 2%)的发生率相似(=0.66)。据我们所知,这是第一项比较 NIRAF 对格雷夫斯病甲状腺切除术术后甲状旁腺功能影响的研究。与传统技术相比,使用 NIRAF 可降低最终病理上偶然甲状旁腺切除术的发生率,而对暂时性或永久性低钙血症的发生率没有影响。